- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07942935
Novel Dietary Interventions in Functional Dyspepsia
This pilot study will test whether people with functional dyspepsia can follow two new dietary approaches and whether these diets may improve symptoms. Thirty adults will be randomly assigned to follow a low-histidine diet, a low-tryptophan diet, or a comparison diet for six weeks. The study aims to reduce-not eliminate- intake. The comparison diet provides dietary instructions that are not intended to reduce either nutrient.
The main goal is to determine whether participants intake of these nutrients can change through diet approaches.
Participants will receive nutrition counseling, follow the diet assigned, describe food consumption during dietary-recall interviews, complete questionnaires, provide blood and urine samples, and swallow a capsule that measures movement and gases in the digestive tract before and after the intervention.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: William Hirsch, MD
- 전화번호: 734-936-4998
- 이메일: whirsch@med.umich.edu
연구 장소
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48109
- University of Michigan
-
연락하다:
- William Hirsch, MD
- 전화번호: 734-936-4998
- 이메일: whirsch@med.umich.edu
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- meeting Rome IV criteria for Functional dyspepsia (FD)
- planned esophagogastroduodenoscopy (EGD) as part of clinical care
Exclusion Criteria:
- Documented drug or alcohol use disorder
- Documented history of an eating disorder
- Habitual vegetarian or vegan diet
- Currently pregnant or breastfeeding or anticipating pregnancy during study period
- Unwilling to follow a low histidine or low tryptophan diet
- Unexplained weight loss, dysphagia, or other warning signs that would prompt evaluation with esophagogastroduodenoscopy - if present would need to ensure no evidence of Los Angeles (LA) grade C or D esophagitis or peptic ulcer disease on EGD performed as part of clinical care
- Use of daily opioid pain medication or glucagon-like peptide receptor 1(GLP-1) agonist
- Current use of metoclopramide or other prokinetic medication
- History of gastrointestinal surgery
- Poorly controlled diabetes mellitus (HgbA1c >10%)
- Known allergy to ingredient in Atmo Motility Bar (Rolled oats, glucose syrup, soy nuggets, rice bran crisps, brown rice syrup, pea protein powder, glycerine, natural vanilla extract and monkfruit juice extract)
- Inability to swallow pills the size of large vitamins
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: low histidine diet
Approximately 10 participants between the ages of 18-75 years old. |
Histamine and histidine are used interchangeably in study materials. Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce histidine intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6. |
|
실험적: low tryptophan diet
Approximately 10 participants between the ages of 18-75 years old. |
Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6. |
|
위약 비교기: sham diet
Approximately 10 participants between the ages of 18-75 years old. |
Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary recommendations that will not lead to an impact in dietary histidine or tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in 24-hour dietary histidine
기간: baseline, 6 week
|
Histidine is assessed through 24-hour dietary recall using Nutrition Data System for Research (NDSR) |
baseline, 6 week
|
|
Change in 24-hour dietary tryptophan
기간: baseline, 6 week
|
Tryptophan is assessed through 24-hour dietary recall using NDSR |
baseline, 6 week
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Percentage of participants who meet a 30% reduction in dietary tryptophan
기간: 6 week
|
Tryptophan is assessed through 24-hour dietary recall using NDSR |
6 week
|
|
Percentage of participants who meet a 30% reduction in dietary histidine
기간: 6 week
|
Histidine is assessed through 24-hour dietary recall using NDSR |
6 week
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- HUM00294428
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .